Hainan Meida Pharmaceutical

Hainan Meida Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company and a wholly-owned subsidiary of the publicly traded Lionco Pharmaceutical Group (Lingkang). Established in 2008 and headquartered in Haikou, Hainan, the company focuses on the development and production of chemical drugs using advanced formulation technologies, including liposomes, microspheres, and micronization. Its product portfolio spans several therapeutic areas such as gastroenterology, neurology, cardiovascular health, and infectious diseases. Notable products and pipeline candidates include liposomal formulations of racecadotril and fluoxetine, as well as microsphere-based antibiotics like cefotiam. As a core manufacturing unit within the Lionco Group, Hainan Meida Pharmaceutical plays a significant role in the group's strategy to provide high-quality, improved generic medications to the Chinese market.